Hepatocellular carcinoma laboratory tests

	Hepatocellular carcinoma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes of Hepatocellular carcinoma
Differentiating Hepatocellular carcinoma from other Diseases
Epidemiology & Demographics
Risk Factors
Screening
Natural History, Complications & Prognosis
Diagnosis
Diagnostic study of choice
History and symptoms
Physical Examination
Lab Tests
Electrocardiogram
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Hepatocellular carcinoma laboratory tests On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Hepatocellular carcinoma laboratory tests All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Hepatocellular carcinoma laboratory tests
CDC on Hepatocellular carcinoma laboratory tests
Hepatocellular carcinoma laboratory tests in the news
Blogs on Hepatocellular carcinoma laboratory tests
Directions to Hospitals Treating Hepatocellular carcinoma
Risk calculators and risk factors for Hepatocellular carcinoma laboratory tests

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Alpha fetoprotien test: This is a blood test. AFP(alpha-fetoprotein) can be found in the blood of unborn babies, but it disappears shortly after birth. When the level of AFP is higher than normal, it suggests that the patient may have hepatocellular carcinoma. Detecting AFP can be used to look for early tumors in people with a high risk for hepatocellular carcinoma.